Otrivin Adult Plus Nasal Spray 10ml

Otrivin Plus Nasal Spray is a dual-action formula that unblocks the nose and stops a runny nose.

Otrivin Plus Nasal Spray contains the active ingredients xylometazoline hydrochloride 70 micrograms/spray (0.5 mg/mL) and ipratropium bromide 84 micrograms/spray (0.6 mg/mL). Xylometazoline hydrochloride helps to open up and clear nasal passages by reducing swollen blood vessels. Ipratropium bromide reduces mucus production. Otrivin Plus Nasal Spray provides relief of a blocked and runny nose caused by colds, hay fever or other allergic rhinitis.

Suitable For: Blocked and runny noses

Boxed Contents: 10ml

Size: 10mL

KEY FEATURES

• Clears blocked nose
• Stops runny nose
• Provides relief of a blocked and runny nose caused by colds, hay fever or other allergic rhinitis.
• Dual Action formula
• Unblocks the nose fast

Active Ingredients: Xylometazoline Hydrochloride 70 micrograms/spray (0.5 mg/mL) Ipratropium bromide 84 micrograms/spray (0.6 mg/mL).

Contains: Xylometazoline Hydrochloride 0.5 mg/mL, Ipratropium Bromide 0.6 mg/mL

1 spray in each nostril as needed up to 3 times daily.

Do not use Otrivin Plus:
- If under 18 years.
- If you are allergic to Xylometazoline, Ipratropium or any other ingredients of this medicine.
- After recent operations through the nose or mouth. .
- If you have inflammatory nasal dryness.
-If you are allergic to atropine or similar substances such as hyoscyamine and scopolamine.
- If you have narrow angle glaucoma.
- If you are pregnant.
- If irritation occurs, or if you have signs of allergy, discontinue use.

Ask your doctor or pharmacist before use:
- If you breast feeding.
- If you have any other medical conditions.
- If you are taking other medicines.
- If you suffer from high blood pressure.
- If you suffer from heart disease.
- If you have an overactive thyroid.
- If you have diabetes.
- If you have phaeochromocytoma.
- If you have an enlarged prostate gland.
- If you have problems urinating.
- If you have cystic fibrosis.
- If you are taking or have taken anti-depressants in the past 2 weeks.